stockrow
Friday 6 November 2026
Export ATEC’s income statement to Excel — free account
Alphatec Holdings, Inc.
ATEC Healthcare Medical Devices
Alphatec Holdings, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $764.2 million, up 25.0% from fiscal 2024.
- Revenue
- +12.6%
- EPS
- +81.7%
- Free cash flow
- −149.2%
- Total debt
- −2.27%
Quarter to September 2026, against a year earlier
7.45
0.35
−4.49%
Follow ATEC
Alert me
| Older periods | Dec '25 | Mar '26 | Jun '26 | Sep '26 | |
|---|---|---|---|---|---|
P/E ratio |
+8 more quarters Free account |
0.00 | 0.00 | 0.00 | 0.00 |
P/S ratio |
4.13 | 2.13 | 1.66 | 1.93 | |
P/FCF ratio |
0.00 | 0.00 | 0.00 | 0.00 | |
P/Operating CF |
152.66 | 1,298.28 | 66.03 | 86.13 | |
P/B ratio |
254.09 | 0.00 | 0.00 | 0.00 | |
Price to Tangible BV |
0.00 | 0.00 | 0.00 | 0.00 | |
EV/Sales |
4.66 | 2.68 | 2.22 | 2.49 | |
EV/EBITDA |
155.25 | 43.67 | 29.31 | 25.46 | |
EV/Operating CF |
78.76 | 40.89 | 32.04 | 34.09 | |
EV/FCF |
(807.82) | (2,696.39) | (315.56) | (200.34) | |
Quick Ratio |
1.18 | 1.03 | 0.96 | 1.06 | |
Current Ratio |
2.06 | 1.90 | 1.89 | 2.36 | |
Net Debt/EBITDA |
21.84 | 79.25 | 14.28 | 14.82 | |
Debt/Assets |
71.53% | 63.53% | 64.57% | 68.65% | |
Debt/Equity |
45.54 | (94.99) | (42.32) | (237.62) | |
Asset Turnover |
0.98 | 0.99 | 1.03 | 1.06 | |
Operating CF/Net income |
(0.95) | (0.04) | (0.80) | (3.45) | |
Capex/Depreciation |
(0.55) | (0.53) | (0.75) | (0.72) | |
Interest Coverage |
(0.68) | (1.93) | (0.17) | 0.31 | |
Research and Development Expense of Revenue |
10.68% | 9.14% | 8.51% | 8.14% | |
Selling, General and Administrative Expense of Revenue |
60.44% | 71.34% | 62.76% | 59.91% | |
Intangible Assets out of Total Assets |
0.21 | 0.21 | 0.21 | 0.21 | |
Share Based Compensation of Revenue |
9.11% | 12.32% | 8.50% | 6.31% | |
Graham Net Nets |
(0.10) | (0.21) | (0.26) | (0.23) | |
Graham Number |
0.00 | 0.80 | 1.11 | 0.43 | |
Earnings Yield |
(4.52%) | (7.54%) | (8.21%) | (5.38%) | |
Free Cash Flow Yield |
(0.14%) | (0.05%) | (0.42%) | (0.64%) | |
Revenue per Share |
1.42 | 1.25 | 1.36 | 1.41 | |
Operating CF per Share |
0.14 | 0.01 | 0.13 | 0.12 | |
Capex per Share |
(0.10) | (0.09) | (0.14) | (0.13) | |
Free Cash Flow per Share |
0.04 | (0.08) | (0.01) | (0.01) | |
Cash per Share |
1.07 | 0.91 | 0.76 | 0.51 | |
Shareholders Equity per Share |
0.08 | (0.03) | (0.08) | (0.01) | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
0.08 | (0.03) | (0.08) | (0.01) | |
Free Cash Flow |
5.72 | (13.02) | (1.58) | (1.55) | |
Working Capital |
231.70 | 215.92 | 211.05 | 246.40 | |
Capital Expenditures |
(14.96) | (14.31) | (22.09) | (20.41) | |
Net Current Asset Value |
(327.91) | (348.66) | (354.08) | (371.88) | |
EV/EBIT |
0.00 | 0.00 | 0.00 | 0.00 | |
Capex to Sales |
0.07 | 0.07 | 0.10 | 0.09 | |
Price to Operating Income |
0.00 | 0.00 | 0.00 | 0.00 | |
| Other line items | |||||
Average Receivables |
90.15 | 97.93 | 103.02 | 103.82 | |
Average Payables |
46.94 | 42.40 | 54.67 | 49.25 | |
Average Inventory |
172.35 | 178.45 | 182.32 | 186.88 | |
Average Assets |
783.46 | 792.48 | 790.66 | 792.00 | |
Average Common Equity |
(0.87) | (45.64) | 5.85 | 4.60 |
Columns are period end dates · fundamentals updated 6 Nov 2026